Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1259570.RAi3ljr7BYghdBdHQD9XQlloMOdKuHDtav0rXAZ_OUbjA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1259570.RAi3ljr7BYghdBdHQD9XQlloMOdKuHDtav0rXAZ_OUbjA130_assertion type Assertion NP1259570.RAi3ljr7BYghdBdHQD9XQlloMOdKuHDtav0rXAZ_OUbjA130_head.
- NP1259570.RAi3ljr7BYghdBdHQD9XQlloMOdKuHDtav0rXAZ_OUbjA130_assertion description "[PRDM14 is considered as a potential therapeutic target in metastatic NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1259570.RAi3ljr7BYghdBdHQD9XQlloMOdKuHDtav0rXAZ_OUbjA130_provenance.
- NP1259570.RAi3ljr7BYghdBdHQD9XQlloMOdKuHDtav0rXAZ_OUbjA130_assertion evidence source_evidence_literature NP1259570.RAi3ljr7BYghdBdHQD9XQlloMOdKuHDtav0rXAZ_OUbjA130_provenance.
- NP1259570.RAi3ljr7BYghdBdHQD9XQlloMOdKuHDtav0rXAZ_OUbjA130_assertion SIO_000772 25635434 NP1259570.RAi3ljr7BYghdBdHQD9XQlloMOdKuHDtav0rXAZ_OUbjA130_provenance.
- NP1259570.RAi3ljr7BYghdBdHQD9XQlloMOdKuHDtav0rXAZ_OUbjA130_assertion wasDerivedFrom befree-2016 NP1259570.RAi3ljr7BYghdBdHQD9XQlloMOdKuHDtav0rXAZ_OUbjA130_provenance.
- NP1259570.RAi3ljr7BYghdBdHQD9XQlloMOdKuHDtav0rXAZ_OUbjA130_assertion wasGeneratedBy ECO_0000203 NP1259570.RAi3ljr7BYghdBdHQD9XQlloMOdKuHDtav0rXAZ_OUbjA130_provenance.